Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Though generative AI could make game development faster and easier, the industry is divided on where AI fits into the picture.
Arch Resources and Consol Energy announced plans for a merger to create a new $5.2 billion coal giant called Core Natural Resources.
Both Target and TJ Maxx posted stellar earnings results on the strength of the incredibly resilient US consumer.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The European Commission on Tuesday solidified new tariffs for electric vehicles imported from China. The actual numbers aren’t harsh.
GM is cutting over 1,000 workers, equivalent to roughly 1.3% of its total workforce, from its software and services division.
Functional beverages — drinks producers tout as having health benefits because they have been infused with bioactive compounds.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The World Health Organization has declared mpox to be a public health emergency, and pharmaceutical and healthcare winners have emerged.
But data aside, many have cast doubt on the company’s plan for autonomous ridesharing.
Mars announced on Wednesday that it has agreed to buy snack maker Kellanova, a spin-off from Kellogg’s, for a mouth-watering $35.9 billion.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.